Last quarter (Q ), Opiant Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q, Opiant Pharmaceuticals's net income was $-9.92M. See Opiant Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 17.56M	$ 40.73M	$ 27.40M	$ 40.52M	$ 13.98M	$ 11.76M
Cost of Revenue	$ 3.86M	$ 9.07M	$ 6.20M	$ 7.72M	$ 1.49M	$ 1.41M
Gross Profit	$ 13.69M	$ 31.66M	$ 21.21M	$ 32.80M	$ 12.49M	$ 10.35M
Operating Expense	$ 45.20M	$ 26.50M	$ 23.45M	$ 21.89M	$ 33.68M	$ 8.81M
Operating Income	$ -31.51M	$ 5.16M	$ -2.24M	$ 10.91M	$ -21.19M	$ 1.54M
Net Non Operating Interest Income Expense	$ -1.49M	$ -2.12M	$ -37.13K	$ 437.65K	$ 144.70K	$ 10.40K
Other Income Expense	$ -27.41K	$ -5.69K	$ -8.98K	$ 66.67K	$ -98.29K	$ -3.89K
Pretax Income	$ -33.02M	$ 3.03M	$ -2.29M	$ 11.42M	$ -21.14M	$ 1.55M
Tax Provision	$ 65.31K	$ 24.27K	$ -425.68K	$ -177.24K	$ 51.28K	$ 169.16K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -33.09M	$ 3.01M	$ -1.86M	$ 11.59M	$ -21.20M	$ 1.38M
Basic EPS	$ -6.51	$ 0.68	$ -0.44	$ 2.88	$ -7.10	$ 0.66
Diluted EPS	$ -6.57	$ 0.51	$ -0.44	$ 2.17	$ -7.10	$ 0.31
Basic Average Shares	$ 19.99M	$ 4.46M	$ 4.25M	$ 4.02M	$ 2.99M	$ 2.08M
Diluted Average Shares	$ 22.23M	$ 5.92M	$ 4.25M	$ 5.34M	$ 2.99M	$ 4.39M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 49.07M	$ 35.57M	$ 29.64M	$ 29.61M	$ 35.17M	$ 10.22M
Net Income From Continuing And Discontinued Operation	$ -33.09M	$ 3.01M	$ -1.86M	$ 11.59M	$ -21.20M	$ 1.38M
Normalized Income	$ -33.08M	$ 3.01M	$ -1.85M	$ 11.54M	$ -21.12M	$ 1.38M
Interest Expense	$ 1.72M	$ 2.13M	$ 131.01K	$ 0.00	-	-
EBIT	$ -31.31M	$ 5.16M	$ -2.16M	$ 11.42M	$ -21.19M	$ 1.54M
EBITDA	$ -30.70M	$ 5.82M	$ -1.55M	$ 11.65M	$ -21.19M	$ 1.54M

Currency in USD

Opiant Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing